Houston
,
US
4 - 7 August 2023
Association of Diabetes Care & Education Specialists (ADCES 2023)
Presentation schedule and materials
Saturday, 05 August 2023
09:00
CDT
POSTER
Real-World Effectiveness of Once-Weekly Semaglutide in Glycemic Control and Weight Outcomes in Type 2 Diabetes
Xi Tan1; Victoria Divino2; Josh Noone1; James Amamoo1; Lin Xie1; Katharine Coyle2; Cory L. Gamble1; Mico Guevarra1; Yurek Paprocki1; Aaron A King3
09:00
CDT
POSTER
Preferences for Once-Weekly Basal Insulin Versus Existing Insulins Among Adults with Type 2 Diabetes and Healthcare Providers
David Kerr1; Jigar Rajpura2; Tarlan Namvar2
09:00
CDT
POSTER
Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1 RAs) on Glycemic Control and Weight Outcomes in Type 2 Diabetes
Xi Tan1; Victoria Divino2; Josh Noone1; James Amamoo1; Lin Xie1; Katharine Coyle2; Cory L Gamble1; Mico Guevarra1; Yurek Paprocki1; Aaron A King3
09:00
CDT
POSTER
Adherence and Persistence to Oral Semaglutide versus DPP-4is among People with Type 2 Diabetes in a US Real-World Setting
Lei Lv1; Brenna Brady2; Mico Guevarra1; Josh Noone1; Lin Xie1; Alexander Turchin3
09:00
CDT
POSTER
Real-World Impact of Oral Semaglutide on GLycemic Control and Weight Outcomes Based on Highest Dose Received and Persistence With Treatment in Type 2 DiAbeTEs (RELATE Oral Semaglutide)
James Amamoo1; Riddhi P. Doshi2; Joshua Noone1; Xi Tan1; Lin Xie1; Cory L. Gamble1; Mico Guevarra1; Justin Chen2; Aaron A. King3
09:00
CDT
POSTER
Unmet Needs with Current Basal Insulin Therapy: Insights from US Healthcare Professionals
Cyrus Desouza1; Nathan Laney2; Natalie McCorkle2; Karen Salvesen-Sykes2
09:00
CDT
POSTER
Real world experiences of patients using oral semaglutide for T2D
Caroline Swift1; Judith J Stephenson2; Josh Noone1; Chia-Chen Teng2; Rebecca Conto2; Lin Xie1; Mico Guevarra1; Ivy Tonnu-Mihara2
21:00
CDT
POSTER
REal-World Impact of Once-Weekly Injectable Semaglutide on GLycemic Control and Weight Outcomes Based on Highest Dose Received and Persistence With Treatment in Type 2 DiAbeTEs (RELATE – OW Injectable Semaglutide)
James Amamoo1; Riddhi P. Doshi2; Joshua Noone1; Xi Tan1; Lin Xie1; Cory L. Gamble1; Mico Guevarra1; Justin Chen2; Aaron A. King3
Keywords